Bio-Rad Laboratories (BIO-B) Property, Plant & Equipment (Net) Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bio-Rad Laboratories | - | - | 309.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.79% |
| Dec 31, 2025 | 1.90% |
| Sep 30, 2025 | 2.35% |
| Jun 30, 2025 | 2.69% |
| Mar 31, 2025 | 1.68% |
| Dec 31, 2024 | 1.13% |
| Sep 30, 2024 | 1.92% |
| Jun 30, 2024 | 1.35% |
| Mar 31, 2024 | 0.76% |
| Dec 31, 2023 | 0.79% |
| Sep 30, 2023 | 1.09% |
| Jun 30, 2023 | 0.95% |
| Mar 31, 2023 | 0.27% |
| Dec 31, 2022 | 0.21% |
| Sep 30, 2022 | -1.63% |
| Jun 30, 2022 | -1.31% |
| Mar 31, 2022 | -0.78% |
| Dec 31, 2021 | 0.93% |
| Sep 30, 2021 | 0.08% |
| Jun 30, 2021 | 1.04% |
| Mar 31, 2021 | 1.45% |
| Dec 31, 2020 | 2.34% |
| Sep 30, 2020 | 2.08% |
| Jun 30, 2020 | 1.83% |
| Mar 31, 2020 | 2.57% |
| Dec 31, 2019 | 3.09% |
| Sep 30, 2019 | 3.33% |
| Jun 30, 2019 | 2.54% |
| Mar 31, 2019 | 3.14% |
| Dec 31, 2018 | 4.19% |
| Sep 30, 2018 | 2.64% |
| Jun 30, 2018 | 3.21% |
| Mar 31, 2018 | 3.40% |
| Dec 31, 2017 | 3.43% |
| Sep 30, 2017 | 4.70% |
| Jun 30, 2017 | 5.75% |
| Mar 31, 2017 | 6.47% |
| Dec 31, 2016 | 6.93% |
| Sep 30, 2016 | 6.97% |
| Jun 30, 2016 | 5.61% |
| Mar 31, 2016 | 5.88% |
| Dec 31, 2015 | 5.58% |
| Sep 30, 2015 | 6.18% |
| Jun 30, 2015 | 7.52% |
| Dec 31, 2014 | 7.24% |